Originally developed by Valeant Pharmaceuticals. Later in 2000s licensed to Theratechnologies. Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). Following extensive medical research, Food and Drug Administration in 2010 the medication known as Egrift was officially licensed for treating HIV-related lipodystrophy and received approval in Canada five years later in 2015. In the realm of physique and performance enhancement, tesamorelin is known for its ability to visibly reduce fat while moderately increasing lean muscle mass.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Tesamorelin by Dragon Pharma, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.